atropine has been researched along with norethindrone in 5 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (norethindrone) | Trials (norethindrone) | Recent Studies (post-2010) (norethindrone) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 4,295 | 884 | 303 |
| Protein | Taxonomy | atropine (IC50) | norethindrone (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.808 | |
| Glucocorticoid receptor | Homo sapiens (human) | 0.433 | |
| Progesterone receptor | Homo sapiens (human) | 0.0032 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.433 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.0711 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.433 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.433 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.433 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 4.537 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Croxatto, HB; Hayward, JN; Hilliard, J; Sawyer, CH | 1 |
5 other study(ies) available for atropine and norethindrone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Norethindrone blockade of LH release to intrapituitary infusion of hypothalamic extract.
Topics: Animals; Atropine; Estradiol; Hypothalamo-Hypophyseal System; Hypothalamus; Luteinizing Hormone; Norethindrone; Pituitary Gland; Rabbits; Tissue Extracts | 1966 |